Bio-monitoring the elimination of folic acid-preventable Spina Bifida and anencephaly by Brent, Robert L
Reproductive Toxicology 25 (2008) 395-396 
Contents lists available at Scier 
, . journal  h o I g B G p a g G .  www.elsevier.corn1locate Ireproto:  
Guest Editorial 
Bio-monitoring the elimination of folic acid-preventable spina bifida and 
anencephaly 
A B S T R A C T  
- - - -- -- 
This is an invited editorial that praises the idea of serumlred cell folate monitoring of the elimination of 
folic acid-preventable spina bifida. 
O 2008 Elsevier Inc. All rights reserved. 
Since 1991, we have had unequivocal evidence that folate defi- 
ciency is the primary cause of spina bifida and anencephaly (SBA) 
in most of the world [1,2]. Thus, if all women of reproductive age 
consume enough folic acid, we can eliminate Folic Acid-Preventable 
Spina Bifida and Anencephaly (FAP SBA) by primary prevention. It 
is seldom that we have such an opportunity to prevent severe and 
common birth defects. Unfortunately, we are far from accomplish- 
ing the elimination of these birth defects 131. 
A key feature of the successful polio eradication campaign has 
been timely monitoring of the progress or the lack of it and the 
ability to determine when polio is eradicated in a country [4]. The 
efforts to eliminate folic acid-preventable spina bifida and anen- 
cephaly also need a reliable. timely indicator to determine when 
required folic acid fortification programs have been successfully 
implemented and when a state or a country has prevented all or 
almost all FAP SBA. 
Pre- and post-fortification serum/plasma and/or red blood cell 
folates have been measured in a variety of research designs-from 
nationally representative surveys to convenience samples [5-81. 
These data show that before folic acid fortification the mean 
serumlplasma folate concentration is about 4nglml and rises 
almost immediately to 8 or more nglml after the successful imple- 
mentation of required folic acid fortification programs. Red cell 
folate levels also rise after a period of several months 191. Thus, 
the simple measurement of plasma or red cell folate can provide 
the evidence needed to know if the fortification was successfully 
implemented. 
The implementation of a folic acid fortification program may 
not provide enough folic acid to eliminate FAP SBA. If we knew 
the serum/plasma or RBC folate concentration that would assure 
the prevention of all FAP SBA. surveys of folate concentration in 
women of reproductive age could determine whether or not all 
had folate concentrations above this prevention cut-point. If all 
women were above this cut-point. then we would ltnow that FAP 
SBA was eliminated in that country. Likewise, if there were a signif- 
icant proportion below this prevention cut-point, we would ltnow 
that there was work to be done in the country to increase folic 
acid consumption to a level sufficient to get all women above the 
prevention cut-point. There has yet to be a generally agreed upon 
serum/plasma or RBC folate level that assures the elimination of 
FAP SBA [lo].  In the absence of such a consensus, Bar-Oz and his 
colleagues in a paper in this issue assume that elimination or near 
elimination would occur when all women have a RBC folate of at 
least 900 nmol/L. Given the available evidence, their assumption 
is a reasonable one, albeit one that might go up or down with 
new data. They show that. before fortification, almost no women 
in Ontario had RBC folate levels above 900 nmol/L. After fortifica- 
tion. 40% remained below this cut point and were assumed to be 
at  unnecessary risk. These and other data show that folic acid for- 
tification of flour in Canada has been highly effective in raising RBC 
folateconcentrations and there has been a substantial prevention of 
FAP SBA [7.11.12]. It is likely that, if the concentration of folic acid in 
flour doubled in Canada, most women would have RBC folate con- 
centrations above 900nmol/L and most, if not all, FAP SBA would 
be prevented. 
As important as their paper is in assessing current prevention 
in Ontario, it is more important that they have applied a biomarker 
approach to monitor the progress towards the elimination of FAP 
SBA. Their approach should be considered the current best way to 
determine the proportion of women at  unnecessary risk for FAP 
SBA. It is likely that their method can be improved. We need to 
build consensus and perform studies that will validate the most 
appropriate epidemiological and laboratory methods to assess the 
progress towards the elimination of FAP SBA in every country. A 
serum/plasma and/or RBC folate survey would likely be a more 
timely and less expensive approach to evaluate prevention than 
would surveys of pregnancies affected with SBA. Since blood folates 
rise after fortification, within a year of the implementation of forti- 
fication programs, one can estimate the proportion of women still 
a t  risk of having pregnancies with FAP SBA. It would take several 
years for enough babies to be born with spina bifida and anen- 
cephaly, for the data to be collected and analyzed. and for policy 
recommendations to be made about needed changes in the forti- 
fication program. A folate bio-monitoring program would be less 
expensive and could provide key data for policy within a year of 
fortification. 
Currently no group is funded to design and implement a folate 
bio-monitoring program. For polio eradication. the CDC has had 
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substantial and sustained funding to provide leadership and tech- 121 Czeizel AE. Dudas I. Prevention of the first occurrence of neural-tube defects 
nical assistance to the polio eradication effort. Appropriations by by periconceptional vitamin supplementation. New Engl J Med 1992:327(26): 1832-5. Congress, $200 a year* have been 131 Bell KN. Oakley Jr GP. Tracking the prevention of folic acid-preventable spins 
to the success of this program. Given the success that CDC has had bifida and anencephaly. Birth Defects Res A Clin Mol Teratol 2006:76(9): 
in prevention, it would seem reasonable for Congress also to pro- 654-7. 
vide CDC with sufficient, sustained resources to provide leadership 141 Smith J. Leke R. Adams A. Tangermann RH. Certification of polio eradication: process and lessons learned. Bull World Health Organ 2004:82(1):24-30. 
and technical assistance to accelerate the elimination of FAP SBA 151 Erickson JD. FolicaCid and prevention ofspina bifida and anencephaly. 10 years 
around the world. Alternatively, foundations, other governments after the U.S. Public Health Service recommendation. Morbidity 8, Mortality 
or industries could provide the support for such a center. Weekly Report Recommendations 8, Reports. 2002: 51(RR-13):l-3. [GI Hertrampf E. Cortes F. Folic acid fortification of wheat flour: Chile. Nutr rev 
This global technical assistance center and network should pro- 2004:62(6 Pt 2k.544-8 ldiscussion S91. 
vide any country the epidemiological and laboratory support to 
monitor the progress towards the elimination of FAPSBA.There will 
be many activities and projects for this center. Initially the center 
should: 
1. Help countries to conduct surveys of serum/plasma or RBC folate 
to determine whether or not mandatory folic acid fortification 
programs have been successfully implemented. 
2. Establish a task force to prepare and distribute a manual on how 
to monitor progress towards the elimination of FAP SBA. 
3. Advocate for and use new research that will improve our ability 
to determine progress towards elimination in an accurately and 
timely manner. 
Work to achieve mandatory folic acid fortification should not 
wait for the establishment of this center or its products. The 
mandatory folic acid fortification programs in North America and 
in Chile have been highly successful in preventing birth defects, 
even though no country is known to have eliminated them. There 
remains an urgent need for countries that have yet to require forti- 
fication to implement such programs now. Failure to do so means 
that thousands of children will be born each year with preventable 
spina bifida and anencephaly and that millions of people will have 
unnecessary folate deficiency anemia. Readers of this journal are in 
a unique position to advocate for the urgent elimination of FAP SBA. 
We hope that as many as possible will work to provide the political 
will to prevent these birth defects. 
Disclosure 
Godfrey Oakley is a co-inventor on a CDC-Johnson and Johlison 
patent that would cover adding folic acid to contraceptive pills. He 
has consulted for Johnson and Johnson on this issue. 
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